{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,26]],"date-time":"2026-09-26T01:58:42Z","timestamp":1790387922945,"version":"4.1.0"},"reference-count":32,"publisher":"Springer Science and Business Media LLC","issue":"10","license":[{"start":{"date-parts":[[2026,8,31]],"date-time":"2026-08-31T00:00:00Z","timestamp":1788134400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2026,8,31]],"date-time":"2026-08-31T00:00:00Z","timestamp":1788134400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["HNO"],"published-print":{"date-parts":[[2026,10]]},"DOI":"10.1007\/s00106-026-01797-3","type":"journal-article","created":{"date-parts":[[2026,8,31]],"date-time":"2026-08-31T12:18:17Z","timestamp":1788178697000},"page":"712-720","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Die aktuelle S3-Leitlinie zu Speicheldr\u00fcsentumoren aus HNO-\u00e4rztlicher Sicht","Current German S3 guideline on salivary gland tumors from an otolaryngological perspective"],"prefix":"10.1007","volume":"74","author":[{"given":"Maximilian","family":"Rink","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Luisa","family":"Symeou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Naglaa","family":"Mansour","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tobias","family":"Ettl","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Julian","family":"K\u00fcnzel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,8,31]]},"reference":[{"key":"1797_CR1","unstructured":"AWMF Leitlinienprogramm Onkologie (2025) S3-Leitlinie Diagnostik und Therapie von Speicheldr\u00fcsentumoren des Kopfes. Version 1.0."},{"key":"1797_CR2","doi-asserted-by":"publisher","first-page":"471","DOI":"10.1016\/j.ultrasmedbio.2020.11.010","volume":"47","author":"F Berner","year":"2021","unstructured":"Berner\u00a0F, Koch\u00a0M, M\u00fcller\u00a0SK et\u00a0al (2021) Investigation of Sonographic Criteria for Reliable Identification of T1\u2013T2 Low-Grade Malignant Tumors of the Parotid Gland. Ultrasound Med Biol 47:471\u2013477. https:\/\/doi.org\/10.1016\/j.ultrasmedbio.2020.11.010","journal-title":"Ultrasound in Medicine & Biology"},{"key":"1797_CR3","doi-asserted-by":"publisher","first-page":"511","DOI":"10.1177\/0194599816687744","volume":"156","author":"YM Haidar","year":"2017","unstructured":"Haidar\u00a0YM, Moshtaghi\u00a0O, Mahmoodi\u00a0A et\u00a0al (2017) The Utility of In-Office Ultrasound in the Diagnosis of Parotid Lesions. Otolaryngol Head Neck Surg 156:511\u2013517. https:\/\/doi.org\/10.1177\/0194599816687744","journal-title":"Otolaryngol--head neck surg"},{"key":"1797_CR4","doi-asserted-by":"publisher","first-page":"318","DOI":"10.1055\/a-2481-7248","volume":"46","author":"F Johnson","year":"2025","unstructured":"Johnson\u00a0F, Bozzato\u00a0A, Mansour\u00a0N et\u00a0al (2025) Sonography of Salivary Gland Tumors and Disorders. Ultrasound Int Open 46:318\u2013344. https:\/\/doi.org\/10.1055\/a-2481-7248","journal-title":"Ultraschall Med"},{"key":"1797_CR5","doi-asserted-by":"publisher","first-page":"18","DOI":"10.1111\/j.1749-4486.2007.01598.x","volume":"33","author":"M Kraft","year":"2008","unstructured":"Kraft\u00a0M, Lang\u00a0F, Mihaescu\u00a0A, Wolfensberger\u00a0M (2008) Evaluation of clinician-operated sonography and fine-needle aspiration in the assessment of salivary gland tumours. Clinical Otolaryngology 33:18\u201324. https:\/\/doi.org\/10.1111\/j.1749-4486.2007.01598.x","journal-title":"Clinical Otolaryngology"},{"key":"1797_CR6","doi-asserted-by":"publisher","first-page":"67","DOI":"10.1002\/dc.24097","volume":"47","author":"SJ Farahani","year":"2019","unstructured":"Farahani\u00a0SJ, Baloch\u00a0Z (2019) Retrospective assessment of the effectiveness of the Milan system for reporting salivary gland cytology: A systematic review and meta-analysis of published literature. Diagnostic Cytopathology 47:67\u201387. https:\/\/doi.org\/10.1002\/dc.24097","journal-title":"Diagnostic Cytopathology"},{"key":"1797_CR7","doi-asserted-by":"publisher","first-page":"695","DOI":"10.1002\/lary.24339","volume":"124","author":"BL Witt","year":"2014","unstructured":"Witt\u00a0BL, Schmidt\u00a0RL (2014) Ultrasound-guided core needle biopsy of salivary gland lesions: A systematic review and meta-analysis. Laryngoscope Investig Otolaryngol 124:695\u2013700. https:\/\/doi.org\/10.1002\/lary.24339","journal-title":"The Laryngoscope"},{"key":"1797_CR8","doi-asserted-by":"publisher","first-page":"999","DOI":"10.7863\/ultra.15.08043","volume":"35","author":"C Li","year":"2016","unstructured":"Li\u00a0C, Zhang\u00a0C, Li\u00a0N, Li\u00a0J (2016) Compression Real-time Elastography for Evaluation of Salivary Gland Lesions: A Meta-analysis. J\u00a0of Ultrasound Medicine 35:999\u20131007. https:\/\/doi.org\/10.7863\/ultra.15.08043","journal-title":"J of Ultrasound Medicine"},{"key":"1797_CR9","doi-asserted-by":"publisher","first-page":"166","DOI":"10.1055\/s-0035-1553267","volume":"38","author":"N Mansour","year":"2015","unstructured":"Mansour\u00a0N, Bas\u00a0M, Stock\u00a0K et\u00a0al (2015) Multimodal Ultrasonographic Pathway of Parotid Gland Lesions. Ultraschall in Med 38:166\u2013173. https:\/\/doi.org\/10.1055\/s-0035-1553267","journal-title":"Ultraschall in Med"},{"key":"1797_CR10","doi-asserted-by":"publisher","first-page":"725","DOI":"10.1007\/s00330-018-5609-6","volume":"29","author":"YF Zhang","year":"2019","unstructured":"Zhang\u00a0YF, Li\u00a0H, Wang\u00a0XM, Cai\u00a0YF (2019) Sonoelastography for differential diagnosis between malignant and benign parotid lesions: a meta-analysis. Eur Radiol 29:725\u2013735. https:\/\/doi.org\/10.1007\/s00330-018-5609-6","journal-title":"Eur Radiol"},{"key":"1797_CR11","doi-asserted-by":"publisher","first-page":"1954","DOI":"10.1002\/lary.23396","volume":"122","author":"WG Albergotti","year":"2012","unstructured":"Albergotti\u00a0WG, Nguyen\u00a0SA, Zenk\u00a0J, Gillespie\u00a0MB (2012) Extracapsular dissection for benign parotid tumors: A\u00a0meta-analysis. Laryngoscope Investig Otolaryngol 122:1954\u20131960. https:\/\/doi.org\/10.1002\/lary.23396","journal-title":"The Laryngoscope"},{"key":"1797_CR12","doi-asserted-by":"publisher","first-page":"663","DOI":"10.1016\/j.oooo.2014.02.026","volume":"117","author":"E Foresta","year":"2014","unstructured":"Foresta\u00a0E, Torroni\u00a0A, Di Nardo\u00a0F et\u00a0al (2014) Pleomorphic adenoma and benign parotid tumors: extracapsular dissection vs superficial parotidectomy\u2014review of literature and meta-analysis. Oral Surgery, Oral Medicine, Oral Pathology and Oral Radiology 117:663\u2013676. https:\/\/doi.org\/10.1016\/j.oooo.2014.02.026","journal-title":"Oral Surgery, Oral Medicine, Oral Pathology and Oral Radiology"},{"key":"1797_CR13","doi-asserted-by":"publisher","first-page":"895","DOI":"10.1016\/j.ijom.2019.01.030","volume":"48","author":"YQ Lin","year":"2019","unstructured":"Lin\u00a0YQ, Wang\u00a0Y, Ou\u00a0YM et\u00a0al (2019) Extracapsular dissection versus partial superficial parotidectomy for the treatment of benign parotid tumours. Int J Oral Maxillofac Surg 48:895\u2013901. https:\/\/doi.org\/10.1016\/j.ijom.2019.01.030","journal-title":"International Journal of Oral and Maxillofacial Surgery"},{"key":"1797_CR14","doi-asserted-by":"publisher","first-page":"319","DOI":"10.1016\/j.otohns.2005.04.008","volume":"133","author":"JP Leonetti","year":"2005","unstructured":"Leonetti\u00a0JP, Marzo\u00a0SJ, Petruzzelli\u00a0GJ, Herr\u00a0B (2005) Recurrent Pleomorphic Adenoma of the Parotid Gland. Otolaryngol--head neck surg 133:319\u2013322. https:\/\/doi.org\/10.1016\/j.otohns.2005.04.008","journal-title":"Otolaryngol--head neck surg"},{"key":"1797_CR15","doi-asserted-by":"publisher","first-page":"1402","DOI":"10.1002\/hed.21316","volume":"32","author":"MH Valstar","year":"2010","unstructured":"Valstar\u00a0MH, Van Den Brekel\u00a0MWM, Smeele\u00a0LE (2010) Interpretation of treatment outcome in the clinically node-negative neck in primary parotid carcinoma: A systematic review of the literature. Head Neck 32:1402\u20131411. https:\/\/doi.org\/10.1002\/hed.21316","journal-title":"Head & Neck"},{"key":"1797_CR16","doi-asserted-by":"publisher","DOI":"10.3390\/diagnostics11081467","volume":"11","author":"M Quer","year":"2021","unstructured":"Quer\u00a0M, Hernandez-Prera\u00a0JC, Silver\u00a0CE et\u00a0al (2021) Current Trends and Controversies in the Management of Warthin Tumor of the Parotid Gland. Diagnostics 11:1467. https:\/\/doi.org\/10.3390\/diagnostics11081467","journal-title":"Diagnostics"},{"key":"1797_CR17","doi-asserted-by":"publisher","first-page":"1909","DOI":"10.1200\/JCO.21.00449","volume":"39","author":"JL Geiger","year":"2021","unstructured":"Geiger\u00a0JL, Ismaila\u00a0N, Beadle\u00a0B et\u00a0al (2021) Management of Salivary Gland Malignancy: ASCO Guideline. J\u00a0Clin Oncol 39:1909\u20131941. https:\/\/doi.org\/10.1200\/JCO.21.00449","journal-title":"JCO"},{"key":"1797_CR18","doi-asserted-by":"publisher","first-page":"S142","DOI":"10.1017\/S0022215116000566","volume":"130","author":"S Sood","year":"2016","unstructured":"Sood\u00a0S, McGurk\u00a0M, Vaz\u00a0F (2016) Management of Salivary Gland Tumours: United Kingdom National Multidisciplinary Guidelines. J\u00a0Laryngol Otol 130:S142\u2013S149. https:\/\/doi.org\/10.1017\/S0022215116000566","journal-title":"J Laryngol Otol"},{"key":"1797_CR19","doi-asserted-by":"publisher","first-page":"1021","DOI":"10.1016\/j.oraloncology.2005.06.004","volume":"41","author":"YC Lim","year":"2005","unstructured":"Lim\u00a0YC, Lee\u00a0SY, Kim\u00a0K et\u00a0al (2005) Conservative parotidectomy for the treatment of parotid cancers. Oral Oncol 41:1021\u20131027. https:\/\/doi.org\/10.1016\/j.oraloncology.2005.06.004","journal-title":"Oral Oncology"},{"key":"1797_CR20","doi-asserted-by":"publisher","first-page":"102","DOI":"10.1159\/000503580","volume":"98","author":"GC Park","year":"2020","unstructured":"Park\u00a0GC, Roh\u00a0JL, Cho\u00a0KJ et\u00a0al (2020) Clinically Node-Negative Parotid Gland Cancers: Prognostic Factors of Survival and Surgical Extent. Oncology 98:102\u2013110. https:\/\/doi.org\/10.1159\/000503580","journal-title":"Oncology"},{"key":"1797_CR21","doi-asserted-by":"publisher","first-page":"1042","DOI":"10.1177\/0194599815578104","volume":"152","author":"K Mantsopoulos","year":"2015","unstructured":"Mantsopoulos\u00a0K, Velegrakis\u00a0S, Iro\u00a0H (2015) Unexpected Detection of Parotid Gland Malignancy during Primary Extracapsular Dissection. Otolaryngol Head Neck Surg 152:1042\u20131047. https:\/\/doi.org\/10.1177\/0194599815578104","journal-title":"Otolaryngol--head neck surg"},{"key":"1797_CR22","doi-asserted-by":"publisher","first-page":"118","DOI":"10.1002\/lary.24772","volume":"125","author":"CM Lim","year":"2015","unstructured":"Lim\u00a0CM, Gilbert\u00a0M, Johnson\u00a0JT, Kim\u00a0S (2015) Is level V neck dissection necessary in primary parotid cancer? Laryngoscope Investig Otolaryngol 125:118\u2013121. https:\/\/doi.org\/10.1002\/lary.24772","journal-title":"The Laryngoscope"},{"key":"1797_CR23","doi-asserted-by":"publisher","first-page":"1961","DOI":"10.1002\/hed.27062","volume":"44","author":"G Mannelli","year":"2022","unstructured":"Mannelli\u00a0G, Comini\u00a0LV, Sacchetto\u00a0A et\u00a0al (2022) Estimating survival after salvage surgery for recurrent salivary gland cancers: Systematic review. Head Neck 44:1961\u20131975. https:\/\/doi.org\/10.1002\/hed.27062","journal-title":"Head & Neck"},{"key":"1797_CR24","doi-asserted-by":"publisher","first-page":"272","DOI":"10.1016\/j.radonc.2015.05.010","volume":"118","author":"AD Jensen","year":"2016","unstructured":"Jensen\u00a0AD, Poulakis\u00a0M, Nikoghosyan\u00a0AV et\u00a0al (2016) High-LET radiotherapy for adenoid cystic carcinoma of the head and neck: 15\u00a0years\u2019 experience with raster-scanned carbon ion therapy. Clin Transl Radiat Oncol 118:272\u2013280. https:\/\/doi.org\/10.1016\/j.radonc.2015.05.010","journal-title":"Radiotherapy and Oncology"},{"key":"1797_CR25","doi-asserted-by":"publisher","first-page":"1056","DOI":"10.1002\/hed.26563","volume":"43","author":"K Zakeri","year":"2021","unstructured":"Zakeri\u00a0K, Wang\u00a0H, Kang\u00a0JJ et\u00a0al (2021) Outcomes and prognostic factors of major salivary gland tumors treated with proton beam radiation therapy. Head Neck 43:1056\u20131062. https:\/\/doi.org\/10.1002\/hed.26563","journal-title":"Head & Neck"},{"key":"1797_CR26","doi-asserted-by":"publisher","first-page":"62","DOI":"10.1016\/j.ejca.2018.12.035","volume":"110","author":"W van Boxtel","year":"2019","unstructured":"van Boxtel\u00a0W, Locati\u00a0LD, van Engen-van Grunsven\u00a0ACH et\u00a0al (2019) Adjuvant androgen deprivation therapy for poor-risk, androgen receptor-positive salivary duct carcinoma. Eur J Cancer 110:62\u201370. https:\/\/doi.org\/10.1016\/j.ejca.2018.12.035","journal-title":"European Journal of Cancer"},{"key":"1797_CR27","doi-asserted-by":"publisher","unstructured":"Hanna GJ, Bae JE, Lorch JH et al. (2020) The Benefits of Adjuvant Trastuzumab for HER-2-Positive Salivary Gland Cancers.Oncologist. 2020 Jul;25(7):598-608. https:\/\/doi.org\/10.1634\/theoncologist.2019-0841.","DOI":"10.1634\/theoncologist.2019-0841"},{"key":"1797_CR28","doi-asserted-by":"publisher","DOI":"10.3389\/fonc.2014.00268","author":"SD Karam","year":"2014","unstructured":"Karam\u00a0SD, Rashid\u00a0A, Snider\u00a0JW et\u00a0al (2014) IMRT with Stereotactic Body Radiotherapy Boost for High Risk Malignant Salivary Gland Malignancies: A Case Series. Front Oncol. https:\/\/doi.org\/10.3389\/fonc.2014.00268","journal-title":"Front Oncol"},{"key":"1797_CR29","doi-asserted-by":"publisher","first-page":"147","DOI":"10.1007\/s13566-012-0010-6","volume":"1","author":"SD Karam","year":"2012","unstructured":"Karam\u00a0SD, Snider\u00a0JW, Wang\u00a0H et\u00a0al (2012) Reirradiation of recurrent salivary gland malignancies with fractionated stereotactic body radiation therapy. J\u00a0Radiat Oncol 1:147\u2013153. https:\/\/doi.org\/10.1007\/s13566-012-0010-6","journal-title":"J Radiat Oncol"},{"key":"1797_CR30","doi-asserted-by":"publisher","first-page":"1821","DOI":"10.1093\/annonc\/mdz291","volume":"30","author":"KL Jhaveri","year":"2019","unstructured":"Jhaveri\u00a0KL, Wang\u00a0XV, Makker\u00a0V et\u00a0al (2019) Ado-trastuzumab emtansine (T-DM1) in patients with HER2-amplified tumors excluding breast and gastric\/gastroesophageal junction (GEJ) adenocarcinomas: results from the NCI-MATCH trial (EAY131) subprotocol Q. Facts Views Vis Obgyn 30:1821\u20131830. https:\/\/doi.org\/10.1093\/annonc\/mdz291","journal-title":"Annals of Oncology"},{"key":"1797_CR31","doi-asserted-by":"publisher","first-page":"412","DOI":"10.1016\/j.annonc.2019.11.018","volume":"31","author":"R Kurzrock","year":"2020","unstructured":"Kurzrock\u00a0R, Bowles\u00a0DW, Kang\u00a0H et\u00a0al (2020) Targeted therapy for advanced salivary gland carcinoma based on molecular profiling: results from MyPathway, a phase IIa multiple basket study. Ann Oncol 31:412\u2013421. https:\/\/doi.org\/10.1016\/j.annonc.2019.11.018","journal-title":"Annals of Oncology"},{"key":"1797_CR32","doi-asserted-by":"publisher","first-page":"125","DOI":"10.1200\/JCO.18.00545","volume":"37","author":"H Takahashi","year":"2019","unstructured":"Takahashi\u00a0H, Tada\u00a0Y, Saotome\u00a0T et\u00a0al (2019) Phase II Trial of Trastuzumab and Docetaxel in Patients With Human Epidermal Growth Factor Receptor 2\u2013Positive Salivary Duct Carcinoma. J\u00a0Clin Oncol 37:125\u2013134. https:\/\/doi.org\/10.1200\/JCO.18.00545","journal-title":"JCO"}],"container-title":["HNO"],"original-title":[],"language":"de","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00106-026-01797-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00106-026-01797-3","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00106-026-01797-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,9,26]],"date-time":"2026-09-26T01:03:26Z","timestamp":1790384606000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00106-026-01797-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,8,31]]},"references-count":32,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2026,10]]}},"alternative-id":["1797"],"URL":"https:\/\/doi.org\/10.1007\/s00106-026-01797-3","relation":{},"ISSN":["0017-6192","1433-0458"],"issn-type":[{"value":"0017-6192","type":"print"},{"value":"1433-0458","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,8,31]]},"assertion":[{"value":"26 June 2026","order":1,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"31 August 2026","order":2,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Gem\u00e4\u00df den Richtlinien des Springer Medizin Verlags werden Autorinnen und Autoren sowie die Wissenschaftliche Leitung im Rahmen der Manuskripterstellung und Manuskriptfreigabe aufgefordert, eine vollst\u00e4ndige Erkl\u00e4rung zu ihren finanziellen und nichtfinanziellen Interessen abzugeben.","order":1,"name":"Ethics","label":"Interessenkonflikt","group":{"name":"EthicsHeading","label":"Einhaltung ethischer Richtlinien"}},{"value":"M.\u00a0Rink:\n                      A.\u00a0Finanzielle Interessen: Forschungsf\u00f6rderung zur pers\u00f6nlichen Verf\u00fcgung: Bayerisches Zentrum f\u00fcr Krebsforschung (BZKF) f\u00fcr eine experimentelle Studie zu Speicheldr\u00fcsenmalignomen.\u00a0\u2013 B. Nichtfinanzielle Interessen: Facharzt, Klinik und Poliklinik f\u00fcr Hals\u2011, Nasen- und Ohrenheilkunde am Universit\u00e4tsklinikum Regensburg | Mitgliedschaften: DGHNO und DEGUM.,\n                      L.\u00a0Symeou:\n                      A.\u00a0Finanzielle Interessen:\n                      L.\u00a0Symeou\n                      gibt an, dass kein finanzieller Interessenkonflikt besteht.\u00a0\u2013 B. Nichtfinanzielle Interessen: Angestellte Funktionsober\u00e4rztin in der Klinik und Poliklinik f\u00fcr Hals-Nasen-Ohren-Heilkunde im Universit\u00e4tsklinikum Regensburg.,\n                      N.\u00a0Mansour:\n                      A.\u00a0Finanzielle Interessen: Vortragshonorare oder Kostenerstattung als passiv Teilnehmende: RG-Forum, StreamedUp, Sono4Klinik (Vortragshonorar und Reisekosten) | DEGUM (Reisekosten) | Associate Editor bei Springer\/ European Archives of ORL (Honorar).\u00a0\u2013 B. Nichtfinanzielle Interessen: Arbeitgeber: Universit\u00e4tsklinikum Freiburg | Mitgliedschaften: DGHNO (Vorstand AG Ultraschall & Bildgebende Verfahren) | DAHNO (Stellvertretende Pr\u00e4sidentin) | DEGUM: Vorstand Sektion Kopf-Hals | DKK.,\n                      T.\u00a0Ettl:\n                      A.\u00a0Finanzielle Interessen: Vortragshonorare oder Kostenerstattung als passiv Teilnehmende: Hauptvortr\u00e4ge zum Thema Speicheldr\u00fcsenkarzinome bei der AGOKI 2026 und der DGMKG 2025.\u00a0\u2013 B. Nichtfinanzielle Interessen: Stv. Klinikdirektor der Klinik und Poliklinik f\u00fcr Mund\u2011, Kiefer- und Gesichtschirurgie, Universit\u00e4tsklinikum Regensburg | Mitgliedschaften: DGMKG, AKOPOM | Beratungst\u00e4tigkeit f\u00fcr KLS Martin zum Thema Distraktion und Kiefergelenksendoprothetik | Mitglied der Leitliniengruppe f\u00fcr die Erstellung der S3-Leitlinie zu den Speicheldr\u00fcsentumoren.\n                      J.\u00a0K\u00fcnzel:\n                      A.\u00a0Finanzielle Interessen:\n                      J.\u00a0K\u00fcnzel\n                      gibt an, dass kein finanzieller Interessenkonflikt besteht.\u00a0\u2013 B. Nichtfinanzielle Interessen: Leitender Oberarzt, HNO-Klinik, Uniklinik Regensburg | Vorsitzender der DEGUM Kopf-Hals-Sektion.","order":2,"name":"Ethics","label":"Autorinnen und Autoren","group":{"name":"EthicsHeading","label":"Einhaltung ethischer Richtlinien"}},{"value":"Die vollst\u00e4ndige Erkl\u00e4rung zum Interessenkonflikt der Wissenschaftlichen Leitung finden Sie am Kurs der zertifizierten Fortbildung auf\n                      \n                      .","order":3,"name":"Ethics","label":"Wissenschaftliche Leitung","group":{"name":"EthicsHeading","label":"Einhaltung ethischer Richtlinien"}},{"value":"erkl\u00e4rt, dass f\u00fcr die Publikation dieser CME-Fortbildung keine Sponsorengelder an den Verlag flie\u00dfen.","order":4,"name":"Ethics","label":"Der Verlag","group":{"name":"EthicsHeading","label":"Einhaltung ethischer Richtlinien"}},{"value":"F\u00fcr diesen Beitrag wurden von den Autor\/-innen keine Studien an Menschen oder Tieren durchgef\u00fchrt. F\u00fcr die aufgef\u00fchrten Studien gelten die jeweils dort angegebenen ethischen Richtlinien.","order":5,"name":"Ethics","group":{"name":"EthicsHeading","label":"Einhaltung ethischer Richtlinien"}}]}}